A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HALS / HIV-associated lipodystrophy syndrome

[Related PubMed/MEDLINE]
Total Number of Papers: 22
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HALS  (>> Co-occurring Abbreviation)
Long Form:   HIV-associated lipodystrophy syndrome
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 Body Composition and Metabolic Syndrome Components on Lipodystrophy Different Subtypes Associated with HIV. ART, BMI, PLHA, VFA
2017 Doubly Labeled Water Method and Accelerometer for the Measurement of Energy Expenditure in Human Immunodeficiency Virus-Infected Patients. AM, DLW, HIV, REE, TEE
2016 Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study. cART, CRP, rhGH, suPAR
2016 Pioglitazone therapy for HIV/HAART-associated lipodystrophy syndrome could increase subcutaneous fat mass in non-lipoatrophic but not in lipoatrophic regions. HAART
2015 Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients. FGF23
2015 HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels. TWEAK
2014 Alteration in pancreatic islet function in human immunodeficiency virus. anti-HIV
2014 Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular study. RAL
2014 Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. APL, Cav-1, CGL, FPLD, HAART, HIV, LD-HIV, NNRTIs, NRTIs, PTRF, WS
10  2014 Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS). CD14, HAART, LPS, MD-2, sCD14, TLR4
11  2013 Adipokines in the HIV/HAART-associated lipodystrophy syndrome. HAART
12  2013 Role of mitochondria in HIV infection and associated metabolic disorders: focus on nonalcoholic fatty liver disease and lipodystrophy syndrome. HAART, NAFLD, NNRTIs, NRTIs, PIs
13  2012 Nutrition and the HIV-associated lipodystrophy syndrome. HAART
14  2010 The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials. CI, WMD
15  2008 Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone. CT, DXA
16  2007 Altered expression of nucleoside transporter genes (SLC28 and SLC29) in adipose tissue from HIV-1-infected patients. HAART, NTs, TNF-alpha
17  2006 Toxic metabolic syndrome associated with HAART. HAART
18  2006 [Diabetic ketoacidosis in an HIV-infected patient undergoing antiretroviral therapy]. HAART, PI
19  2005 Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines. PAI-1
20  2004 Impact of switching antiretroviral therapy on lipodystrophy and other metabolic complications: a review. HAART, NRTI, PI
21  2000 Risk factors for the HIV-associated lipodystrophy syndrome in a cross-sectional single-centre study. ---
22  2000 [HIV-associated lipodystrophy syndrome (HALS). The Danish Society of Infectious Diseases]. ---